We use cookies to deliver our online services. Details of the cookies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you agree to our use of cookies. To close this message click close.

Hogan Lovells Expands FDA Practice With Specialist Michael Kasser in Israel

09 October 2013

WASHINGTON, D.C. 9 October 2013 – Hogan Lovells today announced that Michael ("Moshe") Kasser has joined the firm as a Regulatory Specialist in our Food, Drug, Medical Device, and Agriculture group, where he will assist clients on medical device projects worldwide. Moshe will be resident in Rehovot, Israel with an intermittent presence in our Washington, D.C. office.

Hogan Lovells represents more than 70 medical device companies based in Israel, which is one of the foremost incubators of new medical technology in the world.

Kasser joins from the FDA Center for Devices and Radiological Health ("CDRH") where he was an Orthopedic Device Reviewer from 2009 to 2013. At FDA, he reviewed premarket submissions and was the lead reviewer on many multidisciplinary device applications, including premarket approval applications, investigational device exemption applications, de novo applications, 510(k) notifications, and pre-submissions.

"Michael brings us nearly 10 years of materials science experience to add to our already distinguished medical device regulatory practice," said Jonathan Kahan, Co-director of Hogan Lovells' Food, Drug, Medical Device, and Agriculture group. "His expertise in orthopedic combination products further strengthens our outstanding group of attorneys and regulatory scientists."

Kasser holds both a doctorate and a B.S. degree in Materials Science and Engineering from the University of Maryland, College Park. He has also published numerous articles on various topics involving materials science and device regulation.

 
Loading data